GLP-1 Agonists

Research Report Active Lifestyle

GLP-1 Agonists

November 21, 2023 < 1 min read

New Opportunities for Battling Obesity and Driving Growth for the Fitness and Wellness Industry.

At a time when the buzz about healthy lifestyles would seem to have reached its peak, a breakthrough discovery – glucagon – like peptide-1 agonists (GLP-1s) – enters the market, helping more people to lose more weight than ever before.

Opportunity to Improve Outcomes

GLP-1s offer remarkable benefits along with potential drawbacks, including excessive loss of lean body mass. This drawback presents a significant opportunity for the fitness and wellness industry to cater to a previously underserved group intent on losing weight.

Media: Email media@harrisonco.com from your corporate email account to receive free access to the full report.

Please complete the form below to access the full report